Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
about
Adenosine receptor signaling: a key to opening the blood-brain doorBlood brain barrier: a challenge for effectual therapy of brain tumorsEvolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor modelsRemote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrierDifferential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation.A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin.Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.Adenosine receptor signaling modulates permeability of the blood-brain barrier.JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.The biology of brain metastases-translation to new therapiesCalcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelBlood-brain barrier and chemotherapeutic treatment of brain tumors.Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model.Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.Selective permeabilization of the blood-brain barrier at sites of metastasis.New non-oral drug delivery systems for Parkinson's disease treatment.Recent progress in tight junction modulation for improving bioavailability.The blood-brain barrier: structure, function and therapeutic approaches to cross it.MiRNA-200b Regulates RMP7-Induced Increases in Blood-Tumor Barrier Permeability by Targeting RhoA and ROCKII.Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.NOS Expression and NO Function in Glioma and Implications for Patient Therapies.Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.Carboplatin-Loaded PLGA Microspheres for Intracerebral Implantation: In Vivo Characterization.Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB.Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase.Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors.
P2860
Q26795435-9871D46D-6879-4638-ADC6-3A00D0E5DDABQ28081947-354051F1-1238-4D6F-A4A9-A40706953A61Q28082016-DB2762A7-AAAB-404A-A736-DE35BA151590Q28473716-ED919501-615D-4776-9322-AD4888EE4477Q30399021-BC491F7C-A153-48A3-A277-D9A225E8615AQ30428613-6BFEB397-F422-4B51-9736-1FCE87F9A022Q31123144-A6CE3241-F2A2-4ACA-86CC-2D014E5D8448Q33330066-7D65024A-7197-419D-B9D5-1C804E04ACC6Q33387577-DC8D42DA-56ED-43E8-946D-283C63AECBA9Q33464353-EE03AA0B-F44A-4990-8065-271B8D0FFA45Q33966638-49FD49B8-BD43-49DD-A321-03EA25425E72Q33973657-346BD64D-2C8E-4CA6-AF8F-68DC202108FAQ33982753-EA925734-3A0D-43FF-BA60-E8573E4A0F01Q34216355-F05EC36E-3F19-443D-9B0F-C78E39B8E7C2Q35658977-FEEF06F6-57FB-42BC-8292-8FD1BE43E2C7Q35676602-DF62C554-BA83-44F5-A00C-CC20D3ACFF57Q35695284-53B07BF5-C24F-44B5-B788-97CF5F670075Q36345439-6D7A5C18-A1AF-42A8-A9A3-3C40F35DD62FQ36558683-2F393C49-60FC-4847-BA10-73A5655FD36BQ37020323-D559F353-5896-4D06-B678-5E66FBA0326DQ37076589-E0F8ECE5-56A8-410E-8035-D130E155D4AFQ37209324-BCD032E6-95F1-4619-A79B-EC4B685AF3A7Q37281601-705225BF-A24D-4DBA-A130-E390251E337AQ37840165-7915C991-FC89-4C37-9D63-30ABF00501BBQ38190079-3139C151-04A8-4288-9985-1EE5F2A5B96BQ38232202-A772D6C9-EC18-4E97-915C-9DF441E973E9Q38264654-4BCC406C-522E-4F93-AA43-74A5F3D14539Q38401892-FC09BDA0-A368-45BF-AC4E-87015BC12A4BQ38842322-E9AFBEBC-E066-4938-8EC2-869E3F53F43FQ38867048-03BE26A6-9126-4EA6-B6C0-445C3A6DB824Q39013294-E14D528E-469C-4A13-859F-1C97BBD8B19DQ40305852-64D68F84-8E77-40F3-942E-D9381A5A4BCCQ40859254-83A088DE-B3B9-4C74-8C9E-D1F3B2FB3DC6Q41093799-D2A47645-B902-4472-A148-AC4D2FC87089Q42610813-C200E8A1-F26D-411C-AB10-A4276347094AQ43202050-99BA6299-63E1-414A-BE69-E665629D7481Q48419654-BA713048-D738-4D59-A6E1-DB18EDA324CCQ48664460-6AE393B3-9ED7-4561-AC12-F476FE739E78Q48799855-C643E289-A237-47F7-9049-DC07C95519A1Q48828292-49B6764B-5C3A-400F-9BB0-D54BCC1C88FE
P2860
Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Enhanced tumor uptake of carbo ...... n of bradykinin analog, RMP-7.
@en
Enhanced tumor uptake of carbo ...... n of bradykinin analog, RMP-7.
@nl
type
label
Enhanced tumor uptake of carbo ...... n of bradykinin analog, RMP-7.
@en
Enhanced tumor uptake of carbo ...... n of bradykinin analog, RMP-7.
@nl
prefLabel
Enhanced tumor uptake of carbo ...... n of bradykinin analog, RMP-7.
@en
Enhanced tumor uptake of carbo ...... n of bradykinin analog, RMP-7.
@nl
P2093
P1433
P1476
Enhanced tumor uptake of carbo ...... n of bradykinin analog, RMP-7.
@en
P2093
P304
125-33; discussion 133-4
P356
10.1097/00006123-199607000-00025
P407
P577
1996-07-01T00:00:00Z